Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
Devices@FDA Release 1 A Catalog of Cleared and Approved Medical Devices.
Help | Download Files | More About PMA

New Search Back To Search Results

Premarket Approval (PMA) Database

Trade Name VIEWPOINT(TM) CK SYSTEM
Classification Name electrosurgical,radio frequency,refractive correction
Generic Name rf electrosurgical device
Applicant REFRACTEC, INC.
PMA Number P010018
Date Received03/14/2001
Decision Date04/11/2002
Product CodeMWD
Docket Number 02M-0174
Date Notice 04/25/2002
Advisory Committee Ophthalmic
Expedited Review Granted? No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement  Approval for the refractec viewpoint ck system. This device is indicated for: temporary reduction of spherical hyperopia in patients who have 0. 75 d to 3. 25 d of cycloplegic spherical hyperopia, less than or equal to 0. 75 d of refractive astigmatism (minus cylinder format), a cycloplegic spherical equivalent of 0. 75 d to 3. 00 d, and are 40 years of age or greater with a documented stability of refraction for the prior 12 month, as demonstrated by a change of less than 0. 50 d in spherical and cylindrical components of the manifest refraction. The magnitude of correction with this treatment diminishes over time, with some patients retaining some or all of their intended refractive correction.

  We welcome your comments and feedback about Devices@FDA. Database Updated 02/06/2009

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH